141 related articles for article (PubMed ID: 9440736)
1. Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience.
Curran D; Sahmoud T; Therasse P; van Meerbeeck J; Postmus PE; Giaccone G
J Clin Oncol; 1998 Jan; 16(1):145-52. PubMed ID: 9440736
[TBL] [Abstract][Full Text] [Related]
2. Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B.
Herndon JE; Green MR; Chahinian AP; Corson JM; Suzuki Y; Vogelzang NJ
Chest; 1998 Mar; 113(3):723-31. PubMed ID: 9515850
[TBL] [Abstract][Full Text] [Related]
3. Reflecting real-world patients with mesothelioma in research: an interim report of baseline characteristics from the ASSESS-meso cohort.
Conway RJH; Smith N; Cooper W; Lynch G; Patole S; Symonds J; Edey A; Maskell NA; Bibby AC; ;
ERJ Open Res; 2023 Nov; 9(6):. PubMed ID: 38174143
[TBL] [Abstract][Full Text] [Related]
4. Nationwide prospective registry database of patients with newly diagnosed untreated pleural mesothelioma in Japan.
Hasegawa S; Shintani Y; Takuwa T; Aoe K; Kato K; Fujimoto N; Hida Y; Morise M; Moriya Y; Morohoshi T; Suzuki H; Chida M; Endo S; Kadokura M; Okumura M; Hattori S; Date H; Yoshino I
Cancer Sci; 2024 Feb; 115(2):507-528. PubMed ID: 38047872
[TBL] [Abstract][Full Text] [Related]
5. Predicting survival for patients with mesothelioma: development of the PLACE prognostic model.
Zhang Y; Li N; Li R; Gu Y; Liu X; Zhang S
BMC Cancer; 2023 Jul; 23(1):698. PubMed ID: 37495975
[TBL] [Abstract][Full Text] [Related]
6. Individualized prediction of survival benefit from postoperative radiotherapy for patients with malignant pleural mesothelioma.
Wo Y; Peng Y; Wu Z; Liu P; Shang Y; Shen X; Sun Y
Cancer Med; 2023 Jun; 12(11):12452-12461. PubMed ID: 37076977
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of midkine, syndecan-1, hyaluronan synthase-2, sestrin-1, laminin subunit alpha-4 and fibulin-3 for malignant pleural mesothelioma.
Akgun H; Metintas S; Ak G; Demirkol Canlı S; Isbilen M; Gure AO; Metintas M
Arch Med Sci; 2023; 19(2):355-364. PubMed ID: 37034513
[TBL] [Abstract][Full Text] [Related]
8. Disparities in Survival Due to Social Determinants of Health and Access to Treatment in US Patients With Operable Malignant Pleural Mesothelioma.
Alnajar A; Kareff SA; Razi SS; Rao JS; De Lima Lopes G; Nguyen DM; Villamizar N; Rodriguez E
JAMA Netw Open; 2023 Mar; 6(3):e234261. PubMed ID: 36951862
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and the prognostic role of inflammation indices in malignant pleural mesothelioma.
Ebinç S; Oruç Z; Kalkan Z; Karhan O; Urakçı Z; Küçüköner M; Kaplan MA; Abdurrahman I
Turk Gogus Kalp Damar Cerrahisi Derg; 2023 Jan; 31(1):105-115. PubMed ID: 36926157
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy with immune checkpoint inhibitors and predictive biomarkers in malignant mesothelioma: Work still in progress.
Perrino M; De Vincenzo F; Cordua N; Borea F; Aliprandi M; Santoro A; Zucali PA
Front Immunol; 2023; 14():1121557. PubMed ID: 36776840
[TBL] [Abstract][Full Text] [Related]
11. YAP/TAZ activation predicts clinical outcomes in mesothelioma and is conserved in in vitro model of driver mutations.
Cunningham R; Jia S; Purohit K; Salem O; Hui NS; Lin Y; Carragher NO; Hansen CG
Clin Transl Med; 2023 Feb; 13(2):e1190. PubMed ID: 36740402
[TBL] [Abstract][Full Text] [Related]
12. Contemporary issues in the surgical management of pleural mesothelioma.
Paajanen J; Jaklitsch MT; Bueno R
J Surg Oncol; 2023 Feb; 127(2):343-354. PubMed ID: 36630097
[TBL] [Abstract][Full Text] [Related]
13. Clinical, Laboratory, Histological, Radiological, and Metabolic Features and Prognosis of Malignant Pleural Mesothelioma.
Zhang Y; Li R; Gu Y; LiZhu Y; Liu X; Zhang S
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557076
[No Abstract] [Full Text] [Related]
14. New Insights in Pleural Mesothelioma Classification Update: Diagnostic Traps and Prognostic Implications.
Mastromarino MG; Lenzini A; Aprile V; Alì G; Bacchin D; Korasidis S; Ambrogi MC; Lucchi M
Diagnostics (Basel); 2022 Nov; 12(12):. PubMed ID: 36552912
[TBL] [Abstract][Full Text] [Related]
15. Genomic and transcriptomic analysis of a diffuse pleural mesothelioma patient-derived xenograft library.
Offin M; Sauter JL; Tischfield SE; Egger JV; Chavan S; Shah NS; Manoj P; Ventura K; Allaj V; de Stanchina E; Travis W; Ladanyi M; Rimner A; Rusch VW; Adusumilli PS; Poirier JT; Zauderer MG; Rudin CM; Sen T
Genome Med; 2022 Nov; 14(1):127. PubMed ID: 36380343
[TBL] [Abstract][Full Text] [Related]
16. Proposal for a new local recurrence score in patients with recurrent malignant pleural mesothelioma.
Lauk O; Neuer T; Battilana B; Inci I; Furrer K; Weder W; Hashimoto M; Opitz I
J Thorac Dis; 2022 Aug; 14(8):2835-2844. PubMed ID: 36071779
[TBL] [Abstract][Full Text] [Related]
17. Serum and Pleural Soluble Cell Adhesion Molecules in Mesothelioma Patients: A Retrospective Cohort Study.
Tsagkouli S; Kyriakoulis IG; Kyriakoulis KG; Fyta E; Syrigos A; Bakakos P; Charpidou A; Kotteas E
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740491
[TBL] [Abstract][Full Text] [Related]
18. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma.
Govindan R; Aggarwal C; Antonia SJ; Davies M; Dubinett SM; Ferris A; Forde PM; Garon EB; Goldberg SB; Hassan R; Hellmann MD; Hirsch FR; Johnson ML; Malik S; Morgensztern D; Neal JW; Patel JD; Rimm DL; Sagorsky S; Schwartz LH; Sepesi B; Herbst RS
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35640927
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of maximum standard uptake value, metabolic tumour volume, and total lesion glycolysis of 18F-FDG PET/CT in patients with malignant pleural mesothelioma: a systematic review and meta-analysis.
Wen W; Xu D; Piao Y; Li X
Cancer Cell Int; 2022 Feb; 22(1):60. PubMed ID: 35114996
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Value of
Taralli S; Giancipoli RG; Caldarella C; Scolozzi V; Ricciardi S; Cardillo G; Calcagni ML
J Clin Med; 2021 Dec; 11(1):. PubMed ID: 35011772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
